NL-OMON48162撤回2 期
A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy - INCMGA00012 progressive Squamous Carcinoma Anal Canal phase 2 Study
Incyte Biosciences Benelux B.V.0 个研究点目标入组 2 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Male and female participants at least 18 years of age with locally advanced or
- •metastatic SCAC who have progressed after platinum-based chemotherapy.
- •According to Protocol version 4, dated 08-Jul-2019 an update of the criteria:
- •a Prior 2 lines of systemic therapy for metastatic disease are permitted.
- •b Participants who are ineligible for platinum must have received at least 1
- •prior line of systemic therapy.
- •c. Participants receiving platinum-based radiosensitizing chemotherapy are
- •eligible if relapse occurs within 6 months from completion of treatment.
排除标准
- •Toxicity of prior therapy that has not recovered to <= Grade 1 or baseline (with
- •the exception of any grade of alopecia and anemia not requiring transfusion
研究者
相似试验
进行中（未招募）
1 期
A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM 202)Squamous Carcinoma of the Anal CanalMedDRA version: 20.0Level: LLTClassification code 10002127Term: Anal canal cancer recurrentSystem Organ Class: 100000004864EUCTR2018-002070-51-NLIncyte Corporation81
进行中（未招募）
1 期
A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell CarcinomaEUCTR2018-001627-39-ITINCYTE CORPORATIO60
进行中（未招募）
1 期
A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM-202)EUCTR2018-002070-51-ITIncyte Corporation81
进行中（未招募）
1 期
A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell CarcinomaEUCTR2018-001627-39-DEIncyte Corporation100
进行中（未招募）
1 期
A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy (POD1UM 202)EUCTR2018-002070-51-BEIncyte Corporation81